On Jan. 15, the Yale School of Medicine launched a poster and online campaign called “Help Us Discover Heroes,” which encourages the public to participate in clinical trials of treatment methods for various disorders. Read more: yaledailynews.com
Our Blog
2016: The Year of Diversity in Clinical Trials
Controlled clinical trials provide a critical base of evidence for evaluating whether a medical product is effective before the product is approved for marketing. Read more: blogs.fda.gov
Does Marketing Have Too Much Control In Big Pharma Clinical Trials?
Currently, there are few documented examples of marketing trials. Nonetheless, there are reasons why marketing trials should be of concern to patients and physicians. Read more: forbes.com
FDA faulted for failure to track safety issues with drugs already on market
Most Americans assume that drugs approved by the Food and Drug Administration are safe to take as directed. But safety concerns often arise only after the drugs go on the market, when companies or doctors tell the FDA about cases of patients who have fallen ill or...
Elsevier Continues Focus on Pharmacovigilance, Updates Sequence Analysis Software
Elsevier, a provider of scientific, technical, and medical information products and services, is continuing its efforts in pharmacovigilance in 2015 with plans to launch a bespoke system for the space in 2016. Read more: genomeweb.com
Bladder Pain Global Clinical Trials Review, H2, 2015
GlobalData's clinical trial report, "Bladder Pain Global Clinical Trials Review, H2, 2015" provides an overview of Bladder Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Pain. Read more: prnewswire.com